Nutrition, Gut Microbiota and Health : Feces Sample Collection in NutriNet-Santé Participants
Launched by INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, FRANCE · Apr 16, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how our diet affects the gut microbiota, which is the collection of tiny organisms living in our intestines. Researchers believe that the balance of these organisms can influence our health, and they want to explore this relationship more deeply. The study will involve collecting stool samples from participants in the NutriNet-Santé cohort, a group of people who have already agreed to share information about their diets and health. By analyzing these samples, the researchers aim to find out how different diets can impact the gut microbiota and, in turn, our overall health.
To participate, you need to be at least 18 years old, live in metropolitan France, and be part of the NutriNet-Santé cohort. If selected, you'll receive a kit at home to collect your stool sample, which you will then send back to the researchers. They will analyze your sample while keeping your identity private. Additionally, a follow-up sample may be requested a couple of months later to see how your gut microbiota may change over time. This research could help us better understand the important connection between what we eat and our health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant in the NutriNet-Santé cohort
- • Age ≥ 18 years
- • Resident of metropolitan France
- • Written comprehension frenc
- Exclusion Criteria:
- • Person subject to a safeguard of justice measure
- • Person belonging to one of the categories of vulnerable persons
- • Diagnosis of COVID-19 (clinically or by PCR) in the month prior to collection
- • Contact with a COVID-19 patient in the month prior to collection
- • Suspicion of COVID-19 in the month preceding collection (clinical signs of infection : fever associated with headache, respiratory signs, os anosmia/ageusia)
About Institut National De La Santé Et De La Recherche Médicale, France
The Institut National de la Santé et de la Recherche Médicale (INSERM) is France's key public research organization dedicated to advancing knowledge in health and biomedical sciences. Established to foster innovation and improve public health outcomes, INSERM conducts a wide range of clinical trials and research initiatives aimed at translating scientific discoveries into effective medical treatments and interventions. With a focus on collaboration among researchers, healthcare professionals, and industry partners, INSERM plays a pivotal role in shaping health policies and enhancing the quality of care in France and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bobigny, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported